questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Globulines
Sérum-globulines
Immunoglobulines
Anticorps
Anticorps anti-insuline
Anticorps anti-insuline : Questions médicales fréquentes
Diagnostic
5
Anticorps
Insuline
Diabète
Tests de laboratoire
Anticorps
Insuline
Glycémie
Résistance à l'insuline
Diabète
Anticorps
Insuline
Pathologie
Antécédents médicaux
Diabète
Maladies auto-immunes
Symptômes
5
Hypoglycémie
Hyperglycémie
Symptômes
Symptômes
Diabète
Anticorps
Évolution
Résistance à l'insuline
Symptômes
Diabète
Symptômes
Anticorps
Prévention
5
Prévention
Mode de vie
Santé
Exercice
Prévention
Insuline
Alimentation
Prévention
Santé
Stress
Glycémie
Anticorps
Vaccination
Anticorps
Recherche
Traitements
5
Traitement
Insuline
Antidiabétiques
Alimentation
Glycémie
Diabète
Corticostéroïdes
Inflammation
Anticorps
Surveillance
Glycémie
Traitement
Enfants
Traitement
Diabète
Complications
5
Complications
Hypoglycémie
Cardiovasculaire
Réversibilité
Complications
Santé
Prévention
Suivi médical
Glycémie
Qualité de vie
Complications
Traitement
Antécédents familiaux
Complications
Diabète
Facteurs de risque
5
Facteurs de risque
Diabète
Obésité
Âge
Facteurs de risque
Diabète
Mode de vie
Sédentarité
Résistance à l'insuline
Stress
Facteurs de risque
Insuline
Maladies auto-immunes
Facteurs de risque
Anticorps
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Anticorps anti-insuline : Questions médicales les plus fréquentes",
"headline": "Anticorps anti-insuline : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Anticorps anti-insuline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-30",
"dateModified": "2026-03-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Anticorps anti-insuline"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Anticorps",
"url": "https://questionsmedicales.fr/mesh/D000906",
"about": {
"@type": "MedicalCondition",
"name": "Anticorps",
"code": {
"@type": "MedicalCode",
"code": "D000906",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.377.715.548.114"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Anticorps anti-insuline",
"alternateName": "Insulin Antibodies",
"code": {
"@type": "MedicalCode",
"code": "D007330",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takumi Komiya",
"url": "https://questionsmedicales.fr/author/Takumi%20Komiya",
"affiliation": {
"@type": "Organization",
"name": "School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University."
}
},
{
"@type": "Person",
"name": "Akihiro Mori",
"url": "https://questionsmedicales.fr/author/Akihiro%20Mori",
"affiliation": {
"@type": "Organization",
"name": "School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University."
}
},
{
"@type": "Person",
"name": "Naohito Nishii",
"url": "https://questionsmedicales.fr/author/Naohito%20Nishii",
"affiliation": {
"@type": "Organization",
"name": "Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University."
}
},
{
"@type": "Person",
"name": "Hitomi Oda",
"url": "https://questionsmedicales.fr/author/Hitomi%20Oda",
"affiliation": {
"@type": "Organization",
"name": "School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University."
}
},
{
"@type": "Person",
"name": "Eri Onozawa",
"url": "https://questionsmedicales.fr/author/Eri%20Onozawa",
"affiliation": {
"@type": "Organization",
"name": "School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Diagnosis and treatment of anti-insulin antibody-mediated labile glycaemia in insulin-treated diabetes.",
"datePublished": "2023-09-01",
"url": "https://questionsmedicales.fr/article/37562398",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/dme.15194"
}
},
{
"@type": "ScholarlyArticle",
"name": "Uncommon triggers of insulin autoimmune syndrome: a case report.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38926797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-024-04616-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insulin Autoimmune Syndrome - An After-Meal Roller Coaster Ride.",
"datePublished": "2024-01-07",
"url": "https://questionsmedicales.fr/article/38863913",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.15605/jafes.039.01.07"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insulinoma presenting with anti-insulin antibodies.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39133227",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1530/EDM-24-0062"
}
},
{
"@type": "ScholarlyArticle",
"name": "In vivo relationship between bound and free insulin in patients with diabetes having anti-insulin antibodies.",
"datePublished": "2023-06-20",
"url": "https://questionsmedicales.fr/article/37781465",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13340-023-00641-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Globulines",
"item": "https://questionsmedicales.fr/mesh/D005916"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sérum-globulines",
"item": "https://questionsmedicales.fr/mesh/D012712"
},
{
"@type": "ListItem",
"position": 6,
"name": "Immunoglobulines",
"item": "https://questionsmedicales.fr/mesh/D007136"
},
{
"@type": "ListItem",
"position": 7,
"name": "Anticorps",
"item": "https://questionsmedicales.fr/mesh/D000906"
},
{
"@type": "ListItem",
"position": 8,
"name": "Anticorps anti-insuline",
"item": "https://questionsmedicales.fr/mesh/D007330"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Anticorps anti-insuline - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Anticorps anti-insuline",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Anticorps anti-insuline",
"description": "Comment diagnostiquer des anticorps anti-insuline ?\nQuels tests sont utilisés pour détecter ces anticorps ?\nQuels sont les signes d'une présence d'anticorps anti-insuline ?\nLes anticorps anti-insuline sont-ils toujours pathologiques ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007330#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Anticorps anti-insuline",
"description": "Quels symptômes sont associés aux anticorps anti-insuline ?\nPeut-on avoir des symptômes sans anticorps anti-insuline ?\nLes symptômes varient-ils selon l'âge ?\nComment les symptômes évoluent-ils avec le temps ?\nLes symptômes sont-ils similaires à ceux du diabète ?",
"url": "https://questionsmedicales.fr/mesh/D007330#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Anticorps anti-insuline",
"description": "Peut-on prévenir la formation d'anticorps anti-insuline ?\nL'exercice physique joue-t-il un rôle préventif ?\nUne alimentation saine peut-elle prévenir ces anticorps ?\nLe stress influence-t-il la formation d'anticorps ?\nLes vaccinations influencent-elles les anticorps anti-insuline ?",
"url": "https://questionsmedicales.fr/mesh/D007330#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Anticorps anti-insuline",
"description": "Comment traiter les anticorps anti-insuline ?\nLes modifications alimentaires aident-elles ?\nLes corticostéroïdes sont-ils efficaces ?\nFaut-il surveiller régulièrement la glycémie ?\nLes traitements sont-ils différents pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D007330#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Anticorps anti-insuline",
"description": "Quelles complications peuvent survenir avec ces anticorps ?\nLes complications sont-elles réversibles ?\nComment prévenir les complications liées aux anticorps ?\nLes complications affectent-elles la qualité de vie ?\nLes complications sont-elles plus fréquentes chez certains groupes ?",
"url": "https://questionsmedicales.fr/mesh/D007330#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Anticorps anti-insuline",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'anticorps anti-insuline ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress est-il un facteur de risque ?\nLes maladies auto-immunes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007330#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer des anticorps anti-insuline ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test sanguin mesure la présence d'anticorps anti-insuline."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter ces anticorps ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests immunologiques comme l'ELISA sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une présence d'anticorps anti-insuline ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des fluctuations glycémiques et une résistance à l'insuline peuvent indiquer leur présence."
}
},
{
"@type": "Question",
"name": "Les anticorps anti-insuline sont-ils toujours pathologiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, ils peuvent être présents sans causer de problèmes de santé."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique de diabète ou d'autres maladies auto-immunes est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux anticorps anti-insuline ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent hypoglycémie, hyperglycémie et fluctuations de la glycémie."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans anticorps anti-insuline ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres facteurs peuvent causer des symptômes similaires sans anticorps."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la santé générale."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver si la résistance à l'insuline augmente."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à ceux du diabète ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être similaires, rendant le diagnostic plus complexe."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la formation d'anticorps anti-insuline ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle préventif ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la sensibilité à l'insuline."
}
},
{
"@type": "Question",
"name": "Une alimentation saine peut-elle prévenir ces anticorps ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fibres et faible en sucres peut aider à prévenir des problèmes."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la formation d'anticorps ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la régulation de la glycémie et des anticorps."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles les anticorps anti-insuline ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent avoir un impact, mais les recherches sont encore en cours."
}
},
{
"@type": "Question",
"name": "Comment traiter les anticorps anti-insuline ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des ajustements de l'insuline et des médicaments antidiabétiques."
}
},
{
"@type": "Question",
"name": "Les modifications alimentaires aident-elles ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut aider à gérer la glycémie."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'inflammation mais ne ciblent pas directement les anticorps."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller régulièrement la glycémie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est essentielle pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier en fonction de l'âge et du développement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces anticorps ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'hypoglycémie sévère et des problèmes cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux anticorps ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un contrôle glycémique strict sont essentiels."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent réduire la qualité de vie et nécessiter des ajustements de traitement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des antécédents familiaux de diabète sont plus à risque."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de diabète et l'obésité sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'anticorps anti-insuline ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente généralement avec l'âge, surtout après 45 ans."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire augmente le risque de résistance à l'insuline."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à la résistance à l'insuline et aux anticorps."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes atteintes de maladies auto-immunes ont un risque accru."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/03/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University.
Animal Emergency Center Fuchu.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
School of Veterinary Nursing & Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
The University of Cambridge Metabolic Research Laboratories, Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K. rsemple@ed.ac.uk gb466@cam.ac.uk.
University of Edinburgh Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh, U.K.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, People's Republic of China.
School of Medicine, Xiamen University, Xiamen, Fujian, People's Republic of China.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, People's Republic of China.
National Metabolic Management Center, Xiang'an Hospital of Xiamen University, Xiamen, Fujian, People's Republic of China.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Endocrinology, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, 201700, People's Republic of China.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
School of Medicine, Xiamen University, Xiamen, Fujian, People' s Republic of China.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Novo Nordisk A/S, Vandtårnsvej 114, 2860, Søborg, Denmark. hhaa@novonordisk.com.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Genome Sciences, University of Washington, Seattle, WA, United States.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.
Department of Medicine, Kidney Research Institute, University of Washington, Seattle, WA, United States.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, UCLA, Los Angeles, CA 90095, USA.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
Publications dans "Anticorps anti-insuline" :
2 publications dans cette catégorie
Affiliations :
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON K1A 0R6, Canada.
Publications dans "Anticorps anti-insuline" :
Anti-insulin antibodies in insulin-treated diabetes can derange glycaemia, but are under-recognised. Detection of significant antibodies is complicated by antigenically distinct insulin analogues. We ...
Forty people with insulin-treated diabetes and combinations of insulin resistance, nocturnal/matutinal hypoglycaemia, and unexplained ketoacidosis were studied using broad-specificity insulin immunoas...
Twenty-seven people had insulin immunoreactivity (IIR) below 3000 pmol/L that fell less than 50% after PEG precipitation. Insulin binding by antibodies in this group was low and judged insignificant. ...
Anti-insulin antibodies should be considered in insulin-treated diabetes with unexplained glycaemic lability. Combining immunoassays with PEG precipitation can stratify their significance. Antibody de...
Insulin autoantibody syndrome (IAS), or Hirata disease, is caused by high concentrations of insulin autoantibodies, which result in spontaneous, mainly post-prandial, hypoglycemic episodes. We report ...
A previously healthy 67-year-old Sinhalese man presented with recurrent syncopal attacks for 3 months, which were found to be hypoglycemic episodes. He experienced mainly fasting hypoglycemic attacks,...
Omeprazole-induced insulin autoantibody syndrome is likely in this patient; however, the known hypoglycemic effects of coriander and ginger make it worthwhile to consider a possible association with i...
Hypoglycemic disorders are rare in persons without diabetes, and clinical evaluation to identify its etiology can be challenging. We present a case of insulin autoimmune syndrome induced by carbimazol...
An 89-year-old woman presented with a 6-year history of occasional episodes of impaired consciousness that were relieved by ingestion of a snack. Three months before presenting to our hospital, she ha...
Insulinoma presenting with concomitant anti-insulin antibodies appears rare. Insulin/C-peptide molar ratio and serum insulin concentration are useful for differentiating insulinoma and autoimmune synd...
The Scatchard plot of anti-insulin antibodies is curvilinear, indicating heterogeneity in binding sites. However, the relationship between bound insulin (B) and free insulin (F) in patients with anti-...
We studied two insulin-treated patients with diabetes who had high titers of anti-insulin antibodies. The B and F levels were measured using daily blood samples. Assuming that the law of mass action i...
Some of the B/F vs. B plots of the daily variation showed an approximately linear relationship, while the Scatchard plots of in vitro data became curvilinear....
Our study suggests that the one-site (high-affinity site) of anti-insulin antibodies accounts, for the most part, for insulin pharmacokinetics within physiological insulin concentrations....
The online version contains supplementary material available at 10.1007/s13340-023-00641-1....
Exogenous insulin antibody syndrome (EIAS) is an immunological disorder caused by circulating insulin antibodies (IAs), featuring hypersensitivity to exogenous insulin and insulin resistance. With the...
We describe two cases of diabetes mellitus (DM) with hyperinsulinemia and high serum levels of IAs. They had never been exposed to methimazole, glutathione, lipoic acid, and other sulfhydryl drugs, bu...
We discussed the differences between these two cases of EIAS in clinical manifestations and treatment and summarized all patients of EIAS treated in our department to date....
Development and characterization of guinea pig anti-insulin polyclonal antibody against a target-specific insulin antigen. In India, an insulin immunogenicity kit for detecting insulin antibodies (neu...
Determining the cause of hypoglycemia partly relies on blood insulin and C-peptide assays. Although the pancreatic secretion of these peptides is equimolar, discrepancies in their concentrations may o...
We report the case of a 73-year-old woman with type 2 diabetes mellitus (T2DM) and a history of gastric bypass. The T2DM was initially treated with insulin analogs, which were interrupted due to trans...
Although a discrepancy between blood insulin and C-peptide levels points to insulin analog intake, IAS should also be considered, particularly in a patient with transient hypoglycemia. IAS is characte...
Biotherapeutics have the potential to trigger undesired immune responses in the patients. For therapeutic proteins, immunogenicity is manifested as anti-drug antibodies (ADA). Because ADA could compro...
Exogenous insulin antibody syndrome (EIAS) rarely occurs in type 1 diabetes and should be considered in those with blood glucose levels outside the target range requiring greater than 2 units/kg/day o...
A 17-year-old Caucasian male with type 1 diabetes experienced an abrupt increase in insulin requirements from 1.7 to 3.3 units/kg/day. Total insulin level was 7 µIU/mL with free insulin of 4.8 µIU/mL ...
Mycophenolate mofetil monotherapy is successful in safely treating EIAS in a pediatric patient....